A recent study revealed that suppressing ABCB1 improved the susceptibility of bladder cancer cells to cisplatin by reducing cytotoxic effects and promoting cell death in UBC cells treated with cisplatin [84]. This evidence concerns the gene ABCB1 and urinary bladder carcinoma.